Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance - No Study Results Posted

Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS)

This study has been suspended.

( The study has been suspended for slower than anticipated enrollment to date. )

Study NCT00665652 Information provided by Dartmouth-Hitchcock Medical Center

First Received: April 22, 2008 Last Updated: June 22, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	April 2014
Estimated Primary Completion Date:	April 2014 (Final data collection date for primary outcome measure)